AMRN
Price
$16.22
Change
+$0.51 (+3.25%)
Updated
Jun 30 closing price
Capitalization
357.53M
29 days until earnings call
DARE
Price
$2.39
Change
+$0.02 (+0.84%)
Updated
Jun 30 closing price
Capitalization
21.11M
Interact to see
Advertisement

AMRN vs DARE

Header iconAMRN vs DARE Comparison
Open Charts AMRN vs DAREBanner chart's image
Amarin
Price$16.22
Change+$0.51 (+3.25%)
Volume$170.13K
Capitalization357.53M
Dare Bioscience
Price$2.39
Change+$0.02 (+0.84%)
Volume$38.46K
Capitalization21.11M
AMRN vs DARE Comparison Chart in %
Loading...
AMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMRN vs. DARE commentary
Jul 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRN is a Buy and DARE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 01, 2025
Stock price -- (AMRN: $16.22 vs. DARE: $2.39)
Brand notoriety: AMRN: Notable vs. DARE: Not notable
AMRN represents the Pharmaceuticals: Major, while DARE is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMRN: 137% vs. DARE: 138%
Market capitalization -- AMRN: $357.53M vs. DARE: $21.11M
AMRN [@Pharmaceuticals: Major] is valued at $357.53M. DARE’s [@Biotechnology] market capitalization is $21.11M. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRN’s FA Score shows that 0 FA rating(s) are green whileDARE’s FA Score has 0 green FA rating(s).

  • AMRN’s FA Score: 0 green, 5 red.
  • DARE’s FA Score: 0 green, 5 red.
According to our system of comparison, AMRN is a better buy in the long-term than DARE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRN’s TA Score shows that 5 TA indicator(s) are bullish while DARE’s TA Score has 4 bullish TA indicator(s).

  • AMRN’s TA Score: 5 bullish, 4 bearish.
  • DARE’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, AMRN is a better buy in the short-term than DARE.

Price Growth

AMRN (@Pharmaceuticals: Major) experienced а +28.73% price change this week, while DARE (@Biotechnology) price change was -6.64% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.74%. For the same industry, the average monthly price growth was +2.45%, and the average quarterly price growth was +8.68%.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.71%. For the same industry, the average monthly price growth was +31.92%, and the average quarterly price growth was +6.10%.

Reported Earning Dates

AMRN is expected to report earnings on Jul 30, 2025.

DARE is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+0.74% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

@Biotechnology (+3.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMRN($358M) has a higher market cap than DARE($21.1M). AMRN has higher P/E ratio than DARE: AMRN (67.11) vs DARE (0.10). AMRN YTD gains are higher at: 67.216 vs. DARE (-23.397). DARE has higher annual earnings (EBITDA): -21.82M vs. AMRN (-50.7M). AMRN has more cash in the bank: 321M vs. DARE (10.3M). DARE has less debt than AMRN: DARE (3.57M) vs AMRN (8.74M). AMRN has higher revenues than DARE: AMRN (307M) vs DARE (25.9K).
AMRNDAREAMRN / DARE
Capitalization358M21.1M1,697%
EBITDA-50.7M-21.82M232%
Gain YTD67.216-23.397-287%
P/E Ratio67.110.1067,491%
Revenue307M25.9K1,185,328%
Total Cash321M10.3M3,117%
Total Debt8.74M3.57M245%
FUNDAMENTALS RATINGS
AMRN vs DARE: Fundamental Ratings
AMRN
DARE
OUTLOOK RATING
1..100
8858
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
82
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
93100
PRICE GROWTH RATING
1..100
3689
P/E GROWTH RATING
1..100
10081
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DARE's Valuation (82) in the Biotechnology industry is in the same range as AMRN (87) in the Pharmaceuticals Other industry. This means that DARE’s stock grew similarly to AMRN’s over the last 12 months.

DARE's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as AMRN (100) in the Pharmaceuticals Other industry. This means that DARE’s stock grew similarly to AMRN’s over the last 12 months.

AMRN's SMR Rating (93) in the Pharmaceuticals Other industry is in the same range as DARE (100) in the Biotechnology industry. This means that AMRN’s stock grew similarly to DARE’s over the last 12 months.

AMRN's Price Growth Rating (36) in the Pharmaceuticals Other industry is somewhat better than the same rating for DARE (89) in the Biotechnology industry. This means that AMRN’s stock grew somewhat faster than DARE’s over the last 12 months.

DARE's P/E Growth Rating (81) in the Biotechnology industry is in the same range as AMRN (100) in the Pharmaceuticals Other industry. This means that DARE’s stock grew similarly to AMRN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMRNDARE
RSI
ODDS (%)
Bearish Trend 1 day ago
76%
Bullish Trend 1 day ago
79%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
86%
Momentum
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
78%
MACD
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
77%
Advances
ODDS (%)
Bullish Trend 7 days ago
72%
Bullish Trend 21 days ago
76%
Declines
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 5 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
85%
Aroon
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
AMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EIVAX14.28N/A
N/A
Allspring Special Large Cap Value A
LGOFX29.51N/A
N/A
Lord Abbett Growth Opportunities F
GGGIX64.39N/A
N/A
Gabelli Global Growth I
WPLCX16.24N/A
N/A
WP Large Cap Income Plus Institutional
MKVDX15.95N/A
N/A
MFS International Large Cap Value R1

DARE and

Correlation & Price change

A.I.dvisor indicates that over the last year, DARE has been closely correlated with AZTR. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if DARE jumps, then AZTR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DARE
1D Price
Change %
DARE100%
+1.06%
AZTR - DARE
73%
Closely correlated
+0.50%
CYTK - DARE
42%
Loosely correlated
-0.36%
AXON - DARE
39%
Loosely correlated
+1.14%
AMRN - DARE
34%
Loosely correlated
+3.25%
SNTI - DARE
32%
Poorly correlated
-2.31%
More